Man Wai Chan, Rehan Haidry, Benjamin Norton, Massimiliano di Pietro, Andreas V Hadjinicolaou, Maximilien Barret, Paul Doumbe Mandengue, Stefan Seewald, Raf Bisschops, Philippe Nafteux, Michael J Bourke, Sunil Gupta, Pradeep Mundre, Arnaud Lemmers, Clémence Vuckovic, Oliver Pech, Philippe Leclercq, Emmanuel Coron, Sybren L Meijer, Jacques J G H M Bergman, Roos E Pouw
{"title":"Outcomes after radical endoscopic resection of high risk T1 esophageal adenocarcinoma: an international multicenter retrospective cohort study.","authors":"Man Wai Chan, Rehan Haidry, Benjamin Norton, Massimiliano di Pietro, Andreas V Hadjinicolaou, Maximilien Barret, Paul Doumbe Mandengue, Stefan Seewald, Raf Bisschops, Philippe Nafteux, Michael J Bourke, Sunil Gupta, Pradeep Mundre, Arnaud Lemmers, Clémence Vuckovic, Oliver Pech, Philippe Leclercq, Emmanuel Coron, Sybren L Meijer, Jacques J G H M Bergman, Roos E Pouw","doi":"10.1055/a-2538-9316","DOIUrl":null,"url":null,"abstract":"<p><p>Post-endoscopic resection (ER) management of high risk T1 esophageal adenocarcinoma (EAC) is debated, with conflicting reports on lymph node metastasis (LNM). We aimed to assess outcomes following radical ER for high risk T1 EAC.We identified patients who underwent radical ER (tumor-negative deep margin) of high risk T1 EAC, followed by surgery or endoscopic surveillance, between 2008 and 2019 across 11 international centers.106 patients (86 men; mean [SD] age, 70 [11] years) were included. Of these, 26 (age, 64 [11] years) underwent additional surgery, with residual T1 EAC found in five patients (19%) and LNM in two (8%). After a median [IQR] follow-up of 47 [32-79] months, 2/26 patients (8%) developed LNM/distant metastasis, with one EAC-related death (4%), one unrelated death (4%), and four patients lost to follow-up (15%). Of the 80 patients (age, 71 [9] years) who entered endoscopic surveillance, 5/80 (6%) developed LNM/distant metastasis, with four EAC-related deaths (5%) over 46 (IQR 25-59) months follow-up; there were 15 unrelated deaths (19%), and 10 patients lost to follow-up (13%). The overall rates (95%CI) were: LNM, 6% (2%-12%); LNM/distant metastasis, 7% (3%-13%); EAC-related mortality, 5% (2%-11%); overall mortality, 20% (95%CI 13-29).Our findings present low rates of LNM after radical ER of high risk T1 EAC, consistent with other endoscopy-focused studies. Post-surgical patients are still at risk for metastasis and disease-specific mortality. These results suggest that endoscopic surveillance is suitable for selected cases, but further prospective studies are needed to refine patient selection and confirm optimal outcomes.</p>","PeriodicalId":11516,"journal":{"name":"Endoscopy","volume":" ","pages":"699-708"},"PeriodicalIF":12.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12224666/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endoscopy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2538-9316","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Post-endoscopic resection (ER) management of high risk T1 esophageal adenocarcinoma (EAC) is debated, with conflicting reports on lymph node metastasis (LNM). We aimed to assess outcomes following radical ER for high risk T1 EAC.We identified patients who underwent radical ER (tumor-negative deep margin) of high risk T1 EAC, followed by surgery or endoscopic surveillance, between 2008 and 2019 across 11 international centers.106 patients (86 men; mean [SD] age, 70 [11] years) were included. Of these, 26 (age, 64 [11] years) underwent additional surgery, with residual T1 EAC found in five patients (19%) and LNM in two (8%). After a median [IQR] follow-up of 47 [32-79] months, 2/26 patients (8%) developed LNM/distant metastasis, with one EAC-related death (4%), one unrelated death (4%), and four patients lost to follow-up (15%). Of the 80 patients (age, 71 [9] years) who entered endoscopic surveillance, 5/80 (6%) developed LNM/distant metastasis, with four EAC-related deaths (5%) over 46 (IQR 25-59) months follow-up; there were 15 unrelated deaths (19%), and 10 patients lost to follow-up (13%). The overall rates (95%CI) were: LNM, 6% (2%-12%); LNM/distant metastasis, 7% (3%-13%); EAC-related mortality, 5% (2%-11%); overall mortality, 20% (95%CI 13-29).Our findings present low rates of LNM after radical ER of high risk T1 EAC, consistent with other endoscopy-focused studies. Post-surgical patients are still at risk for metastasis and disease-specific mortality. These results suggest that endoscopic surveillance is suitable for selected cases, but further prospective studies are needed to refine patient selection and confirm optimal outcomes.
高风险T1期食管腺癌(EAC)内镜切除(ER)后的治疗存在争议,淋巴结转移(LNM)的报道相互矛盾。我们旨在评估根治性ER治疗高风险T1期食管腺癌(EAC)的结果。方法:在2008年至2019年期间,我们在11个国际中心确定了接受根治性ER(肿瘤阴性深缘)的高风险T1型EAC患者,随后进行手术或内窥镜监测。结果共纳入106例患者,男性86例,年龄70±11岁。其中,26例(64±11年)患者接受了额外的手术,5例(19%)患者存在T1 EAC残留,2例(8%)患者存在LNM。中位随访47个月(IQR 32-79)后,2/26(8%)发生LNM/远处转移(DM), 1(4%)发生eac相关死亡。无相关性死亡1/26(4%),失访4/26(15%)。80例患者(71±9岁)进入内镜监测。在46个月(IQR 25-59)个月的随访中,5/80(6%)发生LNM/DM, 4/80(5%)发生eac相关死亡。有15/80(19%)例非相关死亡,10/80(13%)例随访丢失。随访期间,LNM的总死亡率为6% (95% CI 2-12), LNM/DM的总死亡率为7% (95% CI 3-13), eac相关死亡率为5% (95% CI 2-11),总死亡率为20% (95% CI 13-29)。结论:我们的研究结果显示高危T1型EAC根治性ER后LNM发生率较低,与其他以内镜为重点的研究结果一致。术后患者仍有转移和疾病特异性死亡的风险。这些结果表明内镜监测适用于选定的病例,但需要进一步的前瞻性研究来完善患者选择并确认最佳结果。
期刊介绍:
Endoscopy is a leading journal covering the latest technologies and global advancements in gastrointestinal endoscopy. With guidance from an international editorial board, it delivers high-quality content catering to the needs of endoscopists, surgeons, clinicians, and researchers worldwide. Publishing 12 issues each year, Endoscopy offers top-quality review articles, original contributions, prospective studies, surveys of diagnostic and therapeutic advances, and comprehensive coverage of key national and international meetings. Additionally, articles often include supplementary online video content.